KIORA PHARMACEUTICALS INC (KPRX)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 17, 2025 | CORRESP | Neutral/Informational | Moderate | Kiora Pharmaceuticals, Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-3. The company seeks to have the registratio… | Read Filing EDGAR |
| Sep. 16, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has communicated to Kiora Pharmaceuticals, Inc. that they will not review the company's registration statement filed on September 15, 2025. The letter emphasizes the compa… | Read Filing EDGAR |
| Jul. 1, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Kiora Pharmaceuticals' Form 10-K for the fiscal year ended December 31, 2024. In their correspondence, they remind the company and its manageme… | Read Filing EDGAR |
| Jun. 20, 2025 | CORRESP | Concern from SEC | Moderate | Kiora Pharmaceuticals, Inc. submitted a response to the SEC's comments regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the pre… | Read Filing EDGAR |
| Jun. 10, 2025 | UPLOAD | Concern from SEC | High | The SEC has conducted a limited review of Kiora Pharmaceuticals' Form 10-K for the fiscal year ended December 31, 2024, and has raised several comments regarding the financial sta… | Read Filing EDGAR |